Low platelet counts alone do not cause bleeding in an experimental model of immune thrombocytopenic purpura in mice

Haematologica

Volumn 88, Issue 6, 2003, Pages 679-687

  Domínguez, Victoria ^a,b   Govezensky, Tzipe ^a   Gevorkian, Goar ^a   Larralde, Carlos ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Anti platelet antibodies; Endothelial cells; Hemorrhagic disease; Immune thrombocytopenic purpura; Murine model

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; POLYCLONAL ANTIBODY; THROMBOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; THROMBOCYTE COUNT; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODY SPECIFICITY; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN G; KINETICS; MICE; MICE, INBRED BALB C; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC; RABBITS;

EID: 0038465902     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. George JN, el-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994;331:1207-11.
2. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
3. Frederiksen H, Schmidt K. The incidence of idiopathic purpura in adults increase with age. Blood 1999;94:909-13.
4. Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic in a mouse model. Blood 2000; 96:2834-40.
5. Hou M, Stockelberg D, Kutti J, Wadenvick H. Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 1995;55:307-14.
6. Kosugi S, Tomiyama Y, Shiraga M, Kashiwagi H, Mizutani H, Kanakura Y, et al. Platelet-associated anti glycoprotein GP IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum antibodies. Thromb Haemost 1996;75:339-45.
7. Kiefel V, Freitag E, Kroll H, Santoso S, Mueller-Eckhardt C. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia. Ann Hematol 1996;72:280-5.
8. Hou M, Stockelberg D, Kutti J, Wadenvik H. Immunoglobulins targeting both gpIIb/IIIa and gpIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies. Br J Haematol 1997; 98:64-7.
9. Hurlimann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by novel ELISA using the purified glycoprotein complexes gpIIb/IIIa and gpIb/IX as antigens. Br J Haematol 1997;98:328-35.
10. Wang ZY, Shen ZX. Megakaryocytes and platelets in Immune thrombocytopenic purpura. Bailliere's Clin Hematol 1997;10: 89-107.
11. Kosugi S, Tomiyama Y, Honda S, Kashiwagi H, Shiraga M, Tadokoro S, et al. Anti-αVβ3 antibodies in chronic immune thrombocytopenic purpura. Thromb Haemost 2001;85:36-41.
12. Pfueller SL, David R, Firkin BG, Bilston RA, Cortizo WF, Raines G. Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia. Br J Haematol 1990;74:336-41.
13. Bierling P, Bettaieb A, Fromont P, Favrin M, Duedari N. Anti-GMP140 (CD62) autoantibody in a patient with autoimmune thrombocytopenic purpura. Br J Haematol 1994;87:631-3.
14. Gevorkian G, Manoutcharian K, Almagro JC, Govezensky T, Dominguez V. Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library. Clin Immunol Immunopathol 1998;86:305-9.
15. Gevorkian G, Manoutcharian K, Govezensky T, Cano JA, Dominguez V, Santamaria H, et al. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura. J Autoimmunity 2000;15:33-40.
16. Fischer P, Jendreyko N, Hoffmann M, Lerch H, Uttenreuther-Fischer MM, Chen PP, et al. Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia. Br J Haematol 1999;105:626-40.
17. Kallianpur A, Jordan J, Brandt S. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 1994;83:1200-8.
18. + bone marrow cells. Blood 2000;95:581-5.
19. Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA, del Zoppo GJ. Integrin αVβ3 is expressed in selected microvessels after cerebral ischemia. Am J Pathol 1996;149:37-44.
20. Byzova TV, Rabbani R, D'Souza S, Plow EF. Role of αVβ3 in vascular biology. Thromb Haemost 1998;80:726-34.
21. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA. Tumor necrosis factor-α modulation of glycoprotein Ibα expression in human endothelial and erythroleukemia cells. Blood 1992; 80:153-61.
22. Beacham DA, Lian J, Wu G, Konkle BA, Ludlow LB, Shapiro SS. Arterial shear stress stimulates surface expression of the endothelial glycoprotein Ib complex. J Cell Biochem 1999; 73:508-21.
23. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a gpIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αvβ3 integrin, and gpIbα. J Exp Med 1998;187:329-39.
24. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leucocyte-endothelial and leucocyte-platelet interaction. Thromb Haemost 1999;81:1-7.
25. Henn V, Steinbach S, Buchner K, Presek P, Kroczek R. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047-54.
26. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000;96:3322-8.
27. Yeh C, Wang WC, Hsieh TT, Huang TF. Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von-Willebrand factor-endothelial cell interaction and inhibits angiogenesis. J Biol Chem 2000;275:18615-8.
28. Ishihara T, Akizuki S, Yokota T, Takahashi M, Uchino F, Matsumoto N. Foamy cells associated with platelet phagocytosis. Am J Pathol 1984;114:104-11.
29. Mizutani H, Furubayashi T, Imai Y, Kashiwagi H, Honda S, Take H, et al. Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP) experimental studies using ITP-prone mice, (NZW x BXSB) F1. Blood 1992;79:942-7.
30. Mizutani H, Furubayashi T, Kashiwagi H, Honda S, Take H, Kurata Y, et al. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production. Thromb Haemost 1992;67:563-6.
31. Nemoto K, Mae T, Saiga K, Matsuura E, Koike T. Autoimmuneprone (NZW x BXSB) F1 mice escape severe thrombocytopenia after treatment with deoxispergualin, an immunosuppressant. Br J Haematol 1995;91:691-6.
32. McKenzie SE, Taylor SM, Malladi P, Yuhan H, Cassel DL, Chien P, et al. The role of the human Fc receptor Fc gamma RIIa in the immune clearence of platelets: a transgenic mouse model. J Immunol 1999;162:4311-8.
33. Wallace PK, Keler T, Coleman K, Fisher J, Vitale L, Graziano RF, et al. Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcγRI), blocks phagocytosis, and modulates receptor expression. J Leuk Biol 1997;62:469-79.
34. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001;291:484-6.
35. Lin S, Kinet J. Giving inhibitory receptors a boost. Science 2001;291:445-6.
36. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000;96:2520-7.
37. Nieswandt B, Echtenacher B, Wachs FP, Schröder J, Gessner JE, Schmidt RE, et al. Acute systemic reaction and lung alterations induced by antiplatelet integrin gpIIb/IIIa antibody in mice. Blood 1999;94:684-93.
38. Hansen RJ, Balthasar JP. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura. J Pharmacol Exp Ther 2001;298:165-71.
39. Woods VL Jr, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-75.
40. Cieutat AM, Rosa JP, Letourneur F, Poncz M, Rifat S. A comparative analysis of cDNA-derived sequences for rat and mouse b3 integrins (gpIIIa) with their human counterpart. Biochem Biophys Res Comm 1993;193:771-8.
41. Becker-Andre M, Hooft van Huijsduijnen R, Losberger C, Whelan J, Delamarter JF. Murine endothelial leukocyte-adhesion molecule 1 is a close structural and functional homologue of the human protein. Eur J Biochem 1992;206: 401-11.
42. Miletich JP. Prothrombin time. In: Beutler E, Litchman MA, Coller BS, Kipps TJ, Editors. Williams Hematology. New York: McGraw-Hill; 1995. p. L82-4.
43. Miletich JP. Activated partial thromboplastin time. In: Beutler E, Litchman MA, Coller BS, Kipps TJ, eds. Williams Hematology. New York: McGraw-Hill; 1995. p. L85-6.
44. Nakajima T, Koyama T, Kakishita E, Nagai K. Inhibitory effects of TTP sera on binding of anti-platelet glycoprotein IIb-IIIa monoclonal antibodies to human vascular endothelial cells. Am J Hematol 1987;25:115-8.
45. Rodriguez-Calvillo M, Gabari I, Duarte M, Mazzolini G, Rifón J, Rocha E, et al. Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelial cells. Exp Hematol 2001;29:589-95.
46. Hajjar KA, Esmon NL, Marcus AJ, Muller WA. Vascular function in hemostasis. In: Beutler, Litchman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams Hematology. New York: McGraw-Hill; 2001. p. 1451-69.
47. Colman RW, Clowes AW, George JN, Hirsh J, Marder VJ. Overview of hemostasis. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 3-16.
48. Koenig DW, Barley-Maloney L, Daniel TO. A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol 1993;13:204-11.
49. Meroni PL, Khamashta MA, Youinou P, Shoenfeld Y. Mosaic of antiendothelial antibodies. Review of the first international workshop on antiendothelial antibodies: clinical and pathological significance. Lupus 1995;4:95-9.
50. Li JS, Liu MF, Lei HY. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity. Clin Immunol Immunopathol 1996;79:211-6.
51. Moscato S, Pratesi F, Bongiorni F, Scavuzzo MC, Chimenti D, Bombardieri S, et al. Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity. J Autoimmun 2002;18:231
52. Hashemi S, Drouin J, Trudel E, Aye MT, Couture R, Page D, et al. Characterization of novel platelet and endothelial cell target antigens in a family with genetic susceptibility to autoimmunity. Am J Hematol 1991;38:293-303.
53. Glynne P, Salama A, Chaudhry A, Swirsky D, Lightstone L Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis 1999;33:133-7.
54. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-74.